These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16505226)

  • 1. Necdin and E2F4 are modulated by rosiglitazone therapy in diabetic human adipose and muscle tissue.
    Goldfine AB; Crunkhorn S; Costello M; Gami H; Landaker EJ; Niinobe M; Yoshikawa K; Lo D; Warren A; Jimenez-Chillaron J; Patti ME
    Diabetes; 2006 Mar; 55(3):640-50. PubMed ID: 16505226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation.
    Albrektsen T; Frederiksen KS; Holmes WE; Boel E; Taylor K; Fleckner J
    Diabetes; 2002 Apr; 51(4):1042-51. PubMed ID: 11916924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necdin-E2F4 interaction provides insulin-sensitizing effect after weight loss induced by gastric bypass surgery.
    Pamuklar ZN; Chen J; Muehlbauer M; Spagnoli A; Torquati A
    Surg Obes Relat Dis; 2013; 9(1):94-9. PubMed ID: 22138333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production.
    Hoo RL; Chow WS; Yau MH; Xu A; Tso AW; Tse HF; Fong CH; Tam S; Chan L; Lam KS
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2777-82. PubMed ID: 17932317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necdin controls proliferation of white adipocyte progenitor cells.
    Fujiwara K; Hasegawa K; Ohkumo T; Miyoshi H; Tseng YH; Yoshikawa K
    PLoS One; 2012; 7(1):e30948. PubMed ID: 22292082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy.
    Tan GD; Debard C; Funahashi T; Humphreys SM; Matsuzawa Y; Frayn KN; Karpe F; Vidal H
    Diabetologia; 2005 Aug; 48(8):1585-9. PubMed ID: 15991021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes.
    Zhou J; Zhou S
    Eur J Pharmacol; 2010 Dec; 649(1-3):390-7. PubMed ID: 20868663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesis.
    Gustafson B; Eliasson B; Smith U
    Diabetologia; 2010 Mar; 53(3):536-40. PubMed ID: 19943155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin.
    Tseng YH; Butte AJ; Kokkotou E; Yechoor VK; Taniguchi CM; Kriauciunas KM; Cypess AM; Niinobe M; Yoshikawa K; Patti ME; Kahn CR
    Nat Cell Biol; 2005 Jun; 7(6):601-11. PubMed ID: 15895078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic modifications of the Zfp/ZNF423 gene control murine adipogenic commitment and are dysregulated in human hypertrophic obesity.
    Longo M; Raciti GA; Zatterale F; Parrillo L; Desiderio A; Spinelli R; Hammarstedt A; Hedjazifar S; Hoffmann JM; Nigro C; Mirra P; Fiory F; Formisano P; Miele C; Smith U; Beguinot F
    Diabetologia; 2018 Feb; 61(2):369-380. PubMed ID: 29067487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the synuclein-γ (SNCG) gene as a PPARγ target in murine adipocytes, dorsal root ganglia somatosensory neurons, and human adipose tissue.
    Dunn TN; Akiyama T; Lee HW; Kim JB; Knotts TA; Smith SR; Sears DD; Carstens E; Adams SH
    PLoS One; 2015; 10(3):e0115830. PubMed ID: 25756178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo.
    Li YY; Wu HS; Tang L; Feng CR; Yu JH; Li Y; Yang YS; Yang B; He QJ
    Pharmacol Res; 2007 Oct; 56(4):335-43. PubMed ID: 17889553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects.
    Walker GE; Marzullo P; Verti B; Guzzaloni G; Maestrini S; Zurleni F; Liuzzi A; Di Blasio AM
    Obesity (Silver Spring); 2008 Sep; 16(9):1983-91. PubMed ID: 19186324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone increases cell surface GLUT4 levels in 3T3-L1 adipocytes through an enhancement of endosomal recycling.
    Martinez L; Berenguer M; Bruce MC; Le Marchand-Brustel Y; Govers R
    Biochem Pharmacol; 2010 May; 79(9):1300-9. PubMed ID: 20026082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of thiazolidinediones on human bone marrow stromal cell differentiation in vitro and in thiazolidinedione-treated patients with type 2 diabetes.
    Beck GR; Khazai NB; Bouloux GF; Camalier CE; Lin Y; Garneys LM; Siqueira J; Peng L; Pasquel F; Umpierrez D; Smiley D; Umpierrez GE
    Transl Res; 2013 Mar; 161(3):145-55. PubMed ID: 23022285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
    Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
    Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin/IGF-I regulation of necdin and brown adipocyte differentiation via CREB- and FoxO1-associated pathways.
    Cypess AM; Zhang H; Schulz TJ; Huang TL; Espinoza DO; Kristiansen K; Unterman TG; Tseng YH
    Endocrinology; 2011 Oct; 152(10):3680-9. PubMed ID: 21862615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model.
    Kim HJ; Jung TW; Kang ES; Kim DJ; Ahn CW; Lee KW; Lee HC; Cha BS
    Metabolism; 2007 May; 56(5):676-85. PubMed ID: 17445544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans.
    Phillips SA; Kung J; Ciaraldi TP; Choe C; Christiansen L; Mudaliar S; Henry RR
    Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E767-73. PubMed ID: 19622782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. v- and t-SNARE protein expression in models of insulin resistance: normalization of glycemia by rosiglitazone treatment corrects overexpression of cellubrevin, vesicle-associated membrane protein-2, and syntaxin 4 in skeletal muscle of Zucker diabetic fatty rats.
    Maier VH; Melvin DR; Lister CA; Chapman H; Gould GW; Murphy GJ
    Diabetes; 2000 Apr; 49(4):618-25. PubMed ID: 10871200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.